AIM
MJN

Achmea Investment Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Achmea Investment Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,936
Closed -$262K – 551
2017
Q1 		$262K Buy
+2,936
New +$241K 0.01% 486

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Achmea Investment Management's MJN Position: Q2 2017 in Review

Achmea Investment Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 2,936 shares — an estimated $262K sold.

Achmea Investment Management first reported a position in MJN in Q1 2017 and held it in 1 quarter. The position peaked at $262K in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Achmea Investment Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Achmea Investment Management sold 2,936 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $262K.
  • Achmea Investment Management first reported a position in Mead Johnson Nutrition Company in Q1 2017 and held it in 1 quarter.
  • Achmea Investment Management's Mead Johnson Nutrition Company position peaked at $262K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Achmea Investment Management's 13F filing for Q2 2017, filed 4 Aug 2017.